BCYC
Price
$7.48
Change
+$0.17 (+2.33%)
Updated
Nov 28 closing price
Capitalization
507.77M
94 days until earnings call
Intraday BUY SELL Signals
MLTX
Price
$13.73
Change
-$0.07 (-0.51%)
Updated
Nov 28 closing price
Capitalization
972.73M
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs MLTX

Header iconBCYC vs MLTX Comparison
Open Charts BCYC vs MLTXBanner chart's image
Bicycle Therapeutics
Price$7.48
Change+$0.17 (+2.33%)
Volume$239.88K
Capitalization507.77M
MoonLake Immunotherapeutics
Price$13.73
Change-$0.07 (-0.51%)
Volume$915.69K
Capitalization972.73M
BCYC vs MLTX Comparison Chart in %
BCYC
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCYC vs. MLTX commentary
Nov 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a StrongBuy and MLTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 30, 2025
Stock price -- (BCYC: $7.48 vs. MLTX: $13.73)
Brand notoriety: BCYC and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 71% vs. MLTX: 14%
Market capitalization -- BCYC: $507.77M vs. MLTX: $972.73M
BCYC [@Biotechnology] is valued at $507.77M. MLTX’s [@Biotechnology] market capitalization is $972.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileMLTX’s FA Score has 1 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • MLTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BCYC and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 6 bearish.
  • MLTX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а +18.35% price change this week, while MLTX (@Biotechnology) price change was +8.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 03, 2026.

MLTX is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($973M) has a higher market cap than BCYC($508M). BCYC YTD gains are higher at: -46.571 vs. MLTX (-74.645). MLTX has higher annual earnings (EBITDA): -196.98M vs. BCYC (-245.86M). BCYC has more cash in the bank: 648M vs. MLTX (425M). BCYC has less debt than MLTX: BCYC (5.74M) vs MLTX (75.8M). BCYC has higher revenues than MLTX: BCYC (28.3M) vs MLTX (0).
BCYCMLTXBCYC / MLTX
Capitalization508M973M52%
EBITDA-245.86M-196.98M125%
Gain YTD-46.571-74.64562%
P/E RatioN/AN/A-
Revenue28.3M0-
Total Cash648M425M152%
Total Debt5.74M75.8M8%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
MLTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ILGJX25.170.14
+0.56%
Columbia Integrated Large Cap Gr Ins 3
ILGRX44.080.16
+0.36%
Macquarie Large Cap Growth Fund R6
PMCKX24.18N/A
N/A
Victory Pioneer Mid Cap Value R6
MCDCX23.36N/A
N/A
BlackRock Emerging Mkts Inv C
RYBCX66.80N/A
N/A
Rydex Basic Materials C

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+2.33%
RPTX - BCYC
50%
Loosely correlated
-1.36%
RGNX - BCYC
44%
Loosely correlated
+0.98%
AUTL - BCYC
42%
Loosely correlated
+2.92%
NRIX - BCYC
42%
Loosely correlated
+2.79%
BHVN - BCYC
41%
Loosely correlated
+5.80%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
-0.51%
KALA - MLTX
87%
Closely correlated
+6.12%
IOBT - MLTX
75%
Closely correlated
-1.96%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-0.35%
NUVL - MLTX
48%
Loosely correlated
+0.27%
More